White label ELPA - ClinicalTrials.eu

Study on Ilofotase Alfa to Prevent Kidney Damage in Patients Undergoing Open Heart Surgery

Not recruiting

2 1
Investigated diseases:
- Renal injury
Investigated drugs:
- Ilofotase Alfa
Study on the Effectiveness and Safety of Gemcitabine, Cisplatin, Trastuzumab, and Pembrolizumab for Untreated HER2-Positive Biliary Tract Cancer Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Cholangiocarcinoma
- Gallbladder cancer
Investigated drugs:
Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Not recruiting

3 1 1 1
Investigated diseases:
- Pleural mesothelioma
Investigated drugs:
+3
Study of Elacestrant for Patients with Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer Who Have Not Used CDK4/6 Inhibitors

Not recruiting

2 1 1 1
Investigated diseases:
- Breast cancer metastatic
Investigated drugs:
- Elacestrant
Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Not recruiting

3 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
Study on the Effects of Trastuzumab Deruxtecan in Patients with Advanced or Metastatic Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Metastatic neoplasm
Investigated drugs:
- Trastuzumab Deruxtecan
Study on Pembrolizumab and Paclitaxel for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer in Patients Resistant to CDK 4/6 Inhibitors

Not recruiting

2 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
- Pembrolizumab
Study on the Effects of Live Vaccines (Measles, Mumps, Rubella, BCG) on Immune System in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Not recruiting

2 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
Study Comparing Aficamten and Metoprolol for Adults with Symptomatic Hypertrophic Cardiomyopathy

Not recruiting

3 1 1
Investigated diseases:
- Hypertrophic cardiomyopathy
Investigated drugs:
+1
Study on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome

Not recruiting

3 1 1
Investigated diseases:
- Myelodysplastic syndrome
Investigated drugs:
- Azacitidine
- Venetoclax
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies